Overview

IV Dexketoprofen vs Placebo in Migranie Attack

Status:
Completed

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

H0 hypothesis: IV dexketoprofen is equivalent to placebo in ceasing migraine attack in emergency department. H1 hypothesis: IV dexketoprofen is not equivalent (superior) to placebo in ceasing migraine attack in emergency department.

Phase:

Phase 4

Details

Lead Sponsor:

Akdeniz University

Treatments:

Dexketoprofen trometamol